US Health Secretary RFK Jr to expand access to unapproved peptides
Summary
U.S. Health Secretary Robert F. Kennedy Jr. has proposed allowing compounding pharmacies to prepare six peptides that the FDA has not approved. The proposal will be published in the Federal Register, followed by a two-week public comment period; health experts have warned that the substances lack human clinical trial data and have unknown long-term effects.Key Facts
- The proposal would loosen restrictions on six peptides, including BPC-157, TB-500, KPV, MOTS-c and Semax.
- Compounding pharmacies prepare or mix ingredients to create medications.
- The proposal came from the health secretary’s office rather than the FDA.
- An FDA advisory panel voted in July to loosen restrictions on the peptides, while FDA staff recommended against doing so.
- Kennedy has previously called himself a fan of the drugs and said he would ease restrictions.
- Online influencers market peptides for unproven uses such as muscle growth, healing and improving skin.
- Health experts have cautioned against using the peptides because of limited human research and unknown long-term effects.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
